FDAUnannounced Inspections of Drug Manufacturers Could Improve Drug Safety — If It Actually HappensEmma Yasinski
FDAMakary’s “Blind Spots” Offers Big Ideas — But Can He Deliver as FDA Commissioner?Suzanne B. Robotti